Déjà Flu: Vaccine Effectiveness Concerns Remain As FDA Panel Stands Pat On Strains
This article was originally published in The Pink Sheet Daily
Executive Summary
Advisory committee supports WHO’s recommendation leaving the flu vaccine the same for the 2014-2015 season, but says increasing effectiveness needs to be explored; industry predicts quadrivalent vaccine use will grow to 50%.